- cafead Oct 13, 2023 at 12:12: PM
via The popular diabetes med Ozempic and its sister weight-loss drug Wegovy are boosting Novo Nordisk to new highs again and again.
The Danish company now expects full-year sales to grow between 32% and 38% at constant exchange rates.
article source
The Danish company now expects full-year sales to grow between 32% and 38% at constant exchange rates.
article source